Submissions received by the Committee

Submissions may be re-ordered by clicking on a column header. They may also be grouped by Organisation/Individual, State/Territory.

Data pager
Data pager
Page size:
 184 items in 10 pages
Data pager
Data pager
Page size:
 184 items in 10 pages
1Robert Heron (PDF 64 KB) 
2Rachel Rogers (PDF 67 KB) 
3Recordati Rare Diseases Australia  (PDF 1339 KB) 
4Fabry Australia  (PDF 5719 KB) 
5Ms Julia Burlison (PDF 72 KB) 
6Mrs Donna Greenhalgh (PDF 118 KB) 
7Specialised Therapeutics Australia (PDF 2325 KB) 
8Cystic Fibrosis Australia (PDF 3140 KB) 
9Mind Medicine Australia (PDF 455 KB) 
10Mirum Pharmaceuticals (PDF 227 KB) 
11MPNAA (PDF 122 KB) 
12Myeloma and Related Diseases Registry (PDF 129 KB) 
13Mr Michael Smith (PDF 1454 KB) 
15Department of Health (PDF 466 KB) 
15.1 Supplementary to submission 15 (PDF 419 KB) 
16Australasian Sleep Association (PDF 127 KB) 
17Dr Falk Pharma Australia Pty Ltd (PDF 829 KB) 
18QIMR Berghofer (PDF 291 KB) 
19PFIC Network (PDF 192 KB) 

(Select multiple items for download by clicking the checkboxes)

Download Selected

About this inquiry

Following a referral on 13 August 2020 from the Minister for Health, The Hon Greg Hunt MP, the Committee will inquire into and report on approval processes for new drugs and novel medical technologies in Australia.

Track Inquiry

Upcoming Public Hearings

11 Mar 2021: Sydney
12 Mar 2021: Sydney

Past Public Hearings

05 Feb 2021: Canberra
03 Sep 2020: Canberra


Inquiry Status

Accepting Submissions


If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at